Atrial natriuretic factor inhibits norepinephrine release in an adrenergic clonal cell line (PC12)

Eur J Pharmacol. 1988 May 20;150(1-2):175-9. doi: 10.1016/0014-2999(88)90765-0.

Abstract

Evidence for a presynaptic neuromodulatory effect of atrial natriuretic factor (ANF) has been obtained in rat adrenal pheochromocytoma cells (PC12), a clonal line that differentiates into adrenergic neuron-like cells when treated with nerve growth factor. ANF had no effect on basal norepinephrine (NE) release. In contrast, ANF markedly and significantly inhibited carbachol-induced NE release in a concentration-dependent manner. This result is consistent with the hypothesis that ANF may be an inhibitory neuromodulator.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Gland Neoplasms / metabolism
  • Animals
  • Atrial Natriuretic Factor / pharmacology*
  • Carbachol / pharmacology
  • Norepinephrine / metabolism*
  • Pheochromocytoma / metabolism
  • Rats
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism*
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Atrial Natriuretic Factor
  • Carbachol
  • Norepinephrine